Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/PD of Hemp-based Topical CBD Products
NCT04741477Phase 1Completed
- Sponsor
- Johns Hopkins University
- Start
- Jul 2021
- Primary completion
- Sep 2022
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of Zygel (2 arms), sponsored by Johns Hopkins University. Primary endpoints: Change in Urine cannabinoids and Change in Blood cannabinoids. Started Jul 2021; status: completed.
02
Drugs
Zygel
Beyond the preview
Go deeper on NCT04741477.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04741477.